Healthcare


 Why Immix Biopharma Inc (IMMX) stock soared 55% on Friday?

Why Immix Biopharma Inc (IMMX) stock soared 55% on Friday?

May 20, 2022 01:21 PM PDT| By Versha Jain

The Immix Biopharma Inc. (NASDAQ: IMMX) stock surged 55% after announcing positive results for its lead drug candidate IMX-110 in the first treatment cycle. The stock traded at US$2.5425 at 1:00 pm ET on Friday. The company said that its lead dru.....

 MCK to ABC: 5 healthcare stocks that returned strong 1-year, YTD gains

MCK to ABC: 5 healthcare stocks that returned strong 1-year, YTD gains

May 13, 2022 11:40 AM PDT| By Versha Jain

Highlights  Bristol-Myers Squibb (NYSE: BMY) has a P/E ratio of 27.0 and a dividend yield of 2.84%. Merck & Company, Inc.'s (NYSE: MRK) P/E ratio is 16.02, and the dividend yield is 3.09%. AbbVie Inc.'s (NYSE: ABBV) dividend yield is .....

 Biohaven (BHVN) stock soars 70% after Q1 results, Pfizer’s (PFE) buy offer

Biohaven (BHVN) stock soars 70% after Q1 results, Pfizer’s (PFE) buy offer

May 10, 2022 11:32 AM PDT| By Versha Jain

Highlights  Drugmaker Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) net product revenue grew 182% YoY to US$123.6 million in the quarter ended March 31, 2022. On Tuesday, Pfizer announced acquiring Biohaven for US$11.6 billion .....

 BioNTech’s (BNTX) Q1 earnings surge on COVID-19 vaccine sales

BioNTech’s (BNTX) Q1 earnings surge on COVID-19 vaccine sales

May 09, 2022 10:06 AM PDT| By Team Kalkine Media

Highlights: BioNTech (BNTX) reported first-quarter FY-2022 revenues of €6.4 billion (US$6.7 billion). The net income for the first quarter of 2022 for BioNTech remained at €3.7 billion (US$3.9 billion). BioNTech confirms its COVID-19.....

 CVS Health reports strong Q1 FY-2022 results to outpace estimates

CVS Health reports strong Q1 FY-2022 results to outpace estimates

May 04, 2022 01:12 PM PDT| By Team Kalkine Media

Highlights: CVS Health Corporation beats Wall Street estimates in Q1 2022 earnings report. CVS reported total revenue of US$76.8 billion in Q1 FY-2022. CVS’s GAAP diluted earnings per share (EPS) remained at US$1.74. CVS Health Corp.....

 Pfizer (PFE) posts Q1 revenue of US$25.7bn as Comirnaty vaccine shines

Pfizer (PFE) posts Q1 revenue of US$25.7bn as Comirnaty vaccine shines

May 03, 2022 01:18 PM PDT| By Team Kalkine Media

Highlights: Pfizer Inc. (NYSE: PFE) reported a strong Q1, FY 2022, revenue of US$25.7 billion on Tuesday. Pfizer posted 82% operational revenue growth in the first quarter of 2022. Pfizer’s direct sales of the Comirnaty vaccine grew to .....

 Why Vaxxinity Inc. (VAXX) stock zoomed over 80% on Friday?

Why Vaxxinity Inc. (VAXX) stock zoomed over 80% on Friday?

April 29, 2022 03:17 PM PDT| By Versha Jain

Highlights Texas-based Vaxxinity is a biotechnology company specializing in vaccines for chronic disorders and infectious diseases. The company launched its IPO in November 2021. The stock price has declined by over 72% since the IPO.  .....

 Eli Lilly’s (LLY) Q1 revenue grows 15% on obesity drug sales

Eli Lilly’s (LLY) Q1 revenue grows 15% on obesity drug sales

April 28, 2022 12:21 PM PDT| By Team Kalkine Media

Highlights: Eli Lilly and Company (LLY) reported a 15% revenue growth in the first quarter. Eli Lilly’s Covid-19 vaccine revenue grew to US$660 million. Its key growth products are Tirzepatide, Trulicity, Verzenio, Jardiance, and Taltz. .....

 Why Evoke Pharma (EVOK) stock soared 139%?

Why Evoke Pharma (EVOK) stock soared 139%?

April 26, 2022 10:56 AM PDT| By Versha Jain

Highlights  Evoke Pharma is a specialty pharmaceutical company focused on drugs for treating gastrointestinal disorders and diseases.   The US Food and Drug Administration (FDA) has granted new drug product exclusivity for the company.....

 Swiss drugmaker Novartis (NVS) Q1 revenue gallops on robust sales

Swiss drugmaker Novartis (NVS) Q1 revenue gallops on robust sales

April 26, 2022 07:41 AM PDT| By Team Kalkine Media

Highlights The company posted core operating income of US$4.08 billion. The revenue for its generic drug unit Sandoz was US$538 million. Novartis announced a share buyback program in December 2021. Swiss drugmaker Novartis AG (NYSE: NVS) .....

 Why Veru Inc. (VERU) stock surged more than 20% today?

Why Veru Inc. (VERU) stock surged more than 20% today?

April 25, 2022 12:29 PM PDT| By Versha Jain

Highlights  Veru Inc. (VERU) is a biopharmaceutical company focused on urology and oncology. VERU stock rose 80.51% YTD and 18.88% in one year. The stock has a market capitalization of US$1.03 billion. Shares of biopharmaceuticals co.....

 CELU to CMPI: Explore top 5 biotech stocks with over 100% YTD return

CELU to CMPI: Explore top 5 biotech stocks with over 100% YTD return

April 25, 2022 11:31 AM PDT| By Versha Jain

Highlights  Sierra Oncology, Inc. (NASDAQ: SRRA) stock grew 150.14% year-to- Voyager Therapeutics, Inc. (NASDAQ: VYGR) generated a 17% return YTD. Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) stock rose 257.04% YTD.  Biotechn.....

 Why Erytech Pharma (ERYP) stock zoomed over 57% on Monday?

Why Erytech Pharma (ERYP) stock zoomed over 57% on Monday?

April 25, 2022 08:23 AM PDT| By Team Kalkine Media

Highlights: The Erytech Pharma SA (NASDAQ: ERYP) stock shoot up by over 57% in premarket on Monday. Investors took great interest in Erytech’s announcement of selling its US manufacturing facility to Catalent. The ERYP stock closed Frida.....

 Walgreens (WBA) shares fall after vaccination slump hit Q2 earnings

Walgreens (WBA) shares fall after vaccination slump hit Q2 earnings

March 31, 2022 10:47 AM PDT| By Team Kalkine Media

Highlights:  Walgreens Boots Alliance announces second-quarter results of the fiscal year 2022. Results showed EPS decreased to US$1.02 from US$1.06 in the year-ago quarter. Walgreens bagged strong sales during the winter months, retaine.....

 BioNTech (BNTX) to propose special cash dividend after Q4 profits soar

BioNTech (BNTX) to propose special cash dividend after Q4 profits soar

March 30, 2022 09:49 AM PDT| By Team Kalkine Media

Highlights:  BioNTech is likely to propose a special cash dividend of EUR2 (US$2.2) per share at the AGM.  The company has delivery orders for 4 billion COVID-19 doses in 2022. It is likely to earmark about EUR1.4 billion to .....

 Top healthcare stocks to watch in Q2: ABBV, BMY, ABC, VRTX & MCK

Top healthcare stocks to watch in Q2: ABBV, BMY, ABC, VRTX & MCK

March 29, 2022 11:16 AM PDT| By Versha Jain

Healthcare sector companies provide healthcare-related products and services. It is one of the sectors with a complex chain of stakeholders, including drugmakers, medical device makers, medical insurance providers, hospitals, healthcare service pro.....

 Why is biotechnology firm Ocugen (OCGN) down in pre-market trading?

Why is biotechnology firm Ocugen (OCGN) down in pre-market trading?

March 04, 2022 07:27 AM PST| By Rupam Roy

Highlights: FDA declined to issue a EUA for Covaxin. The OCGN stock tumbled over 25% in pre-market trading. Ocugen intends to continue its work with the FDA for evaluating the regulatory track for the pediatric utilization of Covaxin. The.....

 Top healthcare stocks: ABBV, UNH, LLY, PFE & DHR to explore in March

Top healthcare stocks: ABBV, UNH, LLY, PFE & DHR to explore in March

March 02, 2022 11:12 AM PST| By Rupam Roy

Highlights AbbVie Inc. (NYSE: ABBV) revenue surged over 7% YoY in Q4, FY21. Pfizer, Inc. (NYSE: PFE) revenue jumped 105% YoY in the fourth quarter of fiscal 2021. Eli Lilly and Co. (NYSE: LLY) fiscal 2021 revenue was up 15% YoY. The healt.....

 Why is ZimVie Inc (ZIMV) stock trending?

Why is ZimVie Inc (ZIMV) stock trending?

March 02, 2022 09:16 AM PST| By Rupam Roy

Highlights Zimmer Biomet said that it completed the spinoff of ZimVie. ZimVie started regular trading on Nasdaq under the ticker "ZIMV". The ZBH stock returned over 3% gains in one month. The stocks of ZimVie Inc. (NASDAQ: ZIMV) began tra.....

 What's next for BHC stock as Q4 revenue shrinks?

What's next for BHC stock as Q4 revenue shrinks?

February 24, 2022 05:38 AM PST| By Raza Naqvi

Bausch Health Companies Inc. (TSX:BHC) announced fourth quarter fiscal 2021 and provided guidance for this year. In Q4 2021, total reported revenues of Bausch Health Companies were US$ 2,196 billion compared to US$ 2,213 billion in the fourth quart.....

Recent Articles






Investing Tips

Previous Next